IBD: the drugs work…but do the patients?

Cohen, Russell D.
April 2003
American Journal of Gastroenterology;Apr2003, Vol. 98 Issue 4, p722
Academic Journal
No abstract available.


Related Articles

  • 14-fold rise in infection risk from strong IBD treatment. Tanday, Sanjay // GP: General Practitioner;4/11/2008, p6 

    The article reports that U.S. researchers found patients with inflammatory bowel disease (IBD) who take multiple immunosuppressants have higher risk to develop infections than patients who do not use the drugs. With this, NICE guidance recommends that immunosuppressants be used to control...

  • Drug Interactions in Inflammatory Bowel Disease. Irving, Peter M.; Shanahan, Fergus; Rampton, David S. // American Journal of Gastroenterology;Jan2008, Vol. 103 Issue 1, p207 

    Patients with inflammatory bowel disease (IBD) often require a combination of drugs, some of which are taken for many years, to control their disease. Some of these drugs have potentially serious side effects, which may be initiated or exacerbated by interaction with other agents used to treat...

  • Fracture risk in IBD sparks GP negligence warning. Kelly, Brian // Pulse;3/31/2003, Vol. 63 Issue 13, p11 

    Reports on the risk for general practitioners to be sued upon failure to prescribe proper bone-sparing drugs on inflammatory bowel disease (IBD) warned by osteoporosis experts in Great Britain. Total number of patients with IBD in the country; Types of recommended drugs to be used by GP;...

  • Inflammatory bowel disease is a risk factor for recurrent venous thromboembolism.  // Inflammatory Bowel Disease Monitor;2011, Vol. 11 Issue 3, p120 

    The article presents a multicenter Austrian study on determining the rate and risk factors for recurrent venous thromboembolism (VTE) in a large cohort of inflammatory bowel disease (IBD) patients and compared with that in patients without IBD. It states that IBD patients are in a high risk and...

  • How to recognize and treat IBD. Lichtenstein, Gary R.; Hanauer, Stephen B.; Peppercorn, Mark A.; Ventura, Marissa // Patient Care;Dec2005, Vol. 39 Issue 12, p36 

    The article discusses how to recognize and treat inflammatory bowel disease (IBD). Crohn's disease and ulcerative colitis are the two most common forms of IBD. Most common presenting symptoms of ulcerative colitis are given. Different classes of drugs for treating IBD are discussed. Dietary and...

  • New Drug Delivery Systems in Inflammatory Bowel Disease: MMX and Tailored Delivery to the Gut. Fiorino, G.; Fries, W.; De La Rue, S. A.; Malesci, A. C.; Repici, A.; Danese, S. // Current Medicinal Chemistry;Jun2010, Vol. 17 Issue 17, p1851 

    Inflammatory bowel diseases are chronic diseases that affect the gastrointestinal tract. Mesalamine, corticosteroids, immunosuppressants and biological agents are currently used to treat these diseases. Due to inadequacies of the currently available delivery systems, a large number of patients...

  • Variación en el cuidado de pacientes con Enfermedad Inflamatoria Intestinal (EII): resultado de una encuesta. Juliao Baños, Fabián; Agudelo Zapata, Yineth; Yepes Delgado, Carlos // Revista Colombiana de Gastroenterología;ene-mar2014, Vol. 29 Issue 1, p11 

    Objectives: The quality of care of our patients with inflammatory bowel disease (IBD) is the principal mechanism through which we can offer an appropriate level of health care for our population. Therefore, it is important to determine variations in care provided for patients by specialists with...

  • IBD and Venous Thromboembolism: A Review. Card, Timothy; Chu, Thomas // Inflammatory Bowel Disease Monitor;2012, Vol. 13 Issue 2, p58 

    Thrombosis has long been recognized as a complication of IBD, and a number of risk factors for VTE, such as inflammation, surgery, use of central venous catheters, and hospitalization are common in IBD. Indeed, VTE complicates up to 3% of all IBD hospital admissions, and there is a marked -...

  • Inflammatory bowel disease in pregnancy. Alstead, E M // Postgraduate Medical Journal;Jan2002, Vol. 78 Issue 915, p23 

    Concerns about sexual health, fertility, and pregnancy are common in patients with inflammatory bowel disease (IBD). Fertility is usually normal, although may be decreased in women with active Crohn's disease. Women with active IBD (especially Crohn's disease) are at risk of having small and...

  • Role of Therapeutic Drug Monitoring for Biologics in IBD. Ward, Mark G.; Irving, Peter M. // Inflammatory Bowel Disease Monitor;2014, Vol. 14 Issue 2, p44 

    The introduction of monoclonal antibody therapy directed against tumor necrosis factor-α revolutionized the modern management of patients with IBD. In spite of this, a proportion of patients do not initially respond to this therapy or, of those that do, some lose response with time. The...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics